EUVIMEDEUVIMED entdecken
Crossref

Pharmacological repurposing of cilostazol to attenuate the progression of pulmonary fibrosis: efficacy validation via integrated network pharmacology and in vivo experimentation

Pranaya L Misar, Kishor V Otari, Vishal V Pande, Pradyumna P Ige

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-05488-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Pranaya L Misar und 3 weiteren Autor:innen. Beteiligte Einrichtung: N.N. Sattha College of Pharmacy, Ahilyanagar, MH, India, 414003. misarpranaya@gmail.com. Hauptthemen laut MEDLINE: Cilostazol, Pulmonary Fibrosis, Anti-Inflammatory Agents, Antioxidants. Die Arbeit nennt 104 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CilostazolPulmonary FibrosisAnti-Inflammatory AgentsAntioxidantsAntifibrotic AgentsAnimalsBleomycinMolecular Docking SimulationMaleNetwork PharmacologyDrug RepositioningLungDisease ProgressionRatsRats, Sprague-DawleyDisease Models, Animal

Stichwörter der Autor:innen

AKTBleomycin-induced pulmonary fibrosisDrug repurposingMolecular dockingNetwork pharmacologyPI3K/AKTSmad pathwayTGF-β/Smad pathwayWnt/β-catenin pathway

Substanzen

CilostazolBleomycinAnti-Inflammatory AgentsAntioxidantsAntifibrotic Agents

Autor:innen und Institutionen

  • N.N. Sattha College of Pharmacy, Ahilyanagar, MH, India, 414003. misarpranaya@gmail.com.
  • Navsahyadri Institute of Pharmacy, Nasrapur, Pune, MH, India, 412213.
  • N.N. Sattha College of Pharmacy, Ahilyanagar, MH, India, 414003.
  • JSPM's Shivajirao Patil Kavekar College of Pharmacy, Latur, MH, India, 41312.

Zitieren

APA

Misar, P. L., Otari, K. V., Pande, V. V., & Ige, P. P. (2026). Pharmacological repurposing of cilostazol to attenuate the progression of pulmonary fibrosis: efficacy validation via integrated network pharmacology and in vivo experimentation. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05488-2

Vancouver

Misar PL, Otari KV, Pande VV, Ige PP. Pharmacological repurposing of cilostazol to attenuate the progression of pulmonary fibrosis: efficacy validation via integrated network pharmacology and in vivo experimentation. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05488-2

BibTeX
@article{Misar2026,
  author = {Misar, Pranaya L and Otari, Kishor V and Pande, Vishal V and Ige, Pradyumna P},
  title = {Pharmacological repurposing of cilostazol to attenuate the progression of pulmonary fibrosis: efficacy validation via integrated network pharmacology and in vivo experimentation},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05488-2}
}
Kostenlos starten →